Puma Biotechnology, Inc.
(NASDAQ : PBYI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.26%196.871.2%$505.95m
GILDGilead Sciences, Inc.
-0.54%73.190.9%$444.63m
BIIBBiogen Inc.
-0.66%328.761.3%$366.17m
CELGCelgene Corporation
-0.28%82.351.2%$329.53m
ILMNIllumina, Inc.
-1.93%315.483.5%$284.85m
REGNRegeneron Pharmaceuticals, Inc.
-1.87%376.972.6%$219.75m
ALXNAlexion Pharmaceuticals, Inc.
0.15%122.122.0%$209.05m
VRTXVertex Pharmaceuticals Incorporated
-1.49%178.621.9%$200.45m
SRPTSarepta Therapeutics, Inc.
0.66%131.3616.4%$167.52m
AAgilent Technologies, Inc.
-0.36%66.001.5%$153.99m
BMRNBioMarin Pharmaceutical Inc.
0.26%99.774.4%$128.69m
LGNDLigand Pharmaceuticals Incorporated
-1.05%200.4723.3%$107.01m
VKTXViking Therapeutics, Inc.
-2.49%14.100.9%$106.05m
NKTRNektar Therapeutics
0.23%49.025.6%$105.70m
EXASExact Sciences Corporation
-1.96%65.9025.3%$96.21m

Company Profile

Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.